Your browser doesn't support javascript.
loading
Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors.
Akhtar, Wasim; Marella, Akranth; Alam, Mohammad Mumtaz; Khan, Mohemmed F; Akhtar, Mymoona; Anwer, Tariq; Khan, Farah; Naematullah, Md; Azam, Faizul; Rizvi, Moshahid A; Shaquiquzzaman, Mohammad.
Afiliação
  • Akhtar W; Drug Design and Medicinal Chemistry Laboratory, Jamia Hamdard, New Delhi, India.
  • Marella A; Fryer Global Regulatory Solutions and Services, Hyderabad, Telangana, India.
  • Alam MM; Drug Design and Medicinal Chemistry Laboratory, Jamia Hamdard, New Delhi, India.
  • Khan MF; Drug Design and Medicinal Chemistry Laboratory, Jamia Hamdard, New Delhi, India.
  • Akhtar M; Drug Design and Medicinal Chemistry Laboratory, Jamia Hamdard, New Delhi, India.
  • Anwer T; Department of Pharmacology, College of Pharmacy, Jazan University, Gizan, Saudi Arabia.
  • Khan F; Department of Biochemistry, Jamia Hamdard, New Delhi, India.
  • Naematullah M; Department of Biochemistry, Jamia Hamdard, New Delhi, India.
  • Azam F; Department of Pharmaceutical Chemistry & Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unaizah, Saudi Arabia.
  • Rizvi MA; The Genome Biology Lab, Jamia Millia Islamia, New Delhi, India.
  • Shaquiquzzaman M; Drug Design and Medicinal Chemistry Laboratory, Jamia Hamdard, New Delhi, India.
Arch Pharm (Weinheim) ; 354(1): e2000116, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33015829

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Inibidores de Ciclo-Oxigenase 2 / Neoplasias / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Inibidores de Ciclo-Oxigenase 2 / Neoplasias / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article